Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment
This study has been completed.
Study NCT00171795. Last updated on November 19, 2007.
Information provided by Novartis
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Traumatic Brain Injury
Additional conditions recognized in this trial
Brain Injuries
Cognition Disorders
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Craniocerebral Trauma
Delirium, Dementia, Amnestic, Cognitive Disorders
Disorders of Environmental Origin
Mental Disorders
Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries
Interventions listed in this trial
Rivastigmine
More general drug interventions related to this trial
Central Nervous System Agents
Cholinergic Agents
Cholinesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Novartis
Back to top of Main Content
